Practices Sectors Private clients

Pharmaceuticals and Healthcare

Agro-Industrial Complex ←
→ IT/TMT

Product

BGP Litigation provides comprehensive legal support on a wide range of issues in the pharmaceutical and healthcare industries, and supports businesses in projects related to the full cycle of pharmaceutical company activities.

BGP Litigation clients include major national and international pharmaceutical and medical device manufacturers.

The firm's background in the sector includes support for M&A transactions, including counselling on compliance with the antitrust legislation as part of their preparation, dispute resolution, including cross-border disputes, counselling on tax, sanctions, customs law, competition law issues, including compliance with the advertising legislation and development of commercial policies, as well as protecting the interests of clients in relation to intellectual property, taking into account the specifics of the business.

BGP Litigation lawyers help build compliance processes in pharmaceutical companies, develop anti-corruption policies and conduct due diligence. The lawyers’ profound knowledge of this sensitive industry with complex regulation documents allows them to build the risk management system properly, thereby minimising the risk of both fines and reputational damage.

As a multi-disciplinary team of lawyers, BGP Litigation also offers effective solutions on data protection, labour relations, Legal Tech solutions for pharmaceutical companies considering the specifics of the industry.

We advised:

An American Manufacturer of Advanced Medical Equipment and Digital Solutions

in a dispute with the customs authorities regarding refund of overpaid VAT for importing medical equipment into Russia

A Manufacturer of Contact Lenses

on monitoring parallel imports and counterfeit contact lenses within Russia and the EAEU

An International Pharmaceutical Company

on application of investment tax incentives

A Leader in Implantology and Aesthetic Dentistry

on wholesale trade in pharmaceutical products and taxation in Russia, including accounting for costs related to providing goods for promotional purposes, taxation of annual bonuses for former employees working abroad, accounting for costs of catering for doctors during training courses, and tax risks when collaborating with self-employed individuals residing abroad

Antiretroviral Medicine Manufacturer

in analysing the current business structure and business plan for launching new production facilities to maximise use of incentives and minimise tax risks

An International Biopharmaceutical Company

as part of a project to invest in a medical startup – a developer of software for supporting medical decision-making and diagnosing internal organ condition based on X-ray (CT/MRI) images using AI. This included conducting comprehensive legal due diligence on the startup and preparing transactional documentation

A Multinational Pharmaceutical Company

in developing a commercial policy for the Russian market to systematise work with counterparties, including establishing grounds for differentiating commercial terms and categorising counterparties

A Leading Russian Distributor of Anti-Cancer Medicines

in connection with a global biopharmaceutical company’s refusal to renew a supply contract, including liaising with the Federal Antimonopoly Service of Russia (FAS) to ensure the contract was concluded under its oversight

An International Medical Company

on registration of trade marks with the TMOIS, including analysing the prospects for protecting the brand against parallel imports in the EAEU and implementing available protection mechanisms

Team

Irina Akimova
Partner, attorney, member of the General Council of the Antimonopoly Experts Association – Competition Law
Anastasia Dudko
Partner, attorney - Intellectual Property and Technology
00

News

07/03/2026 07/03/2026 Press-release
BGP Litigation Wins PREQVECA White Nights Awards 2026
06/09/2026 06/09/2026 Press-release
BGP Litigation Strengthens Its Tax and Customs Practices
06/09/2026 06/09/2026 Press-release
BGP Litigation and the Chamber of Commerce and Industry of the Republic of Bashkortostan signed a cooperation agreement at the St. Petersburg International Economic Forum
05/05/2026 05/05/2026 Press-release
RAA's Investment Arbitration Working Group Led by BGP Litigation's Partner Sergey Morozov Submits an Amicus Curiae Brief to the Court of Justice of the European Union
05/04/2026 05/04/2026 Press-release
BGP Litigation Secures Over RUB 5.6 Billion in Damages from Former RUSNANO Executives
04/14/2026 04/14/2026 Press-release
BGP Litigation Secures Reversal of Appellate Ruling in a Dispute over Reclamation of Property from a Good-Faith Purchaser
BGP Litigation's Dispute Resolution team helped its client, Blago Ertil LLC, an agro-industrial company, secure a reversal of the appellate court ruling in a dispute over the reclamation of the value of several hundred tonnes of sunflower oilseeds stolen by fraudsters.

The dispute involved reclaiming the commodity value from a bona fide purchaser as unjust enrichment.  The cause of action was based on the circumstances of the loss of possession of the commodity by the original owner as a result of the fraud.  The appellate court, referring to the final and binding verdict in a criminal fraud case, concluded that the property had been withdrawn from the original owner's possession against his will and ruled that the defendant should pay the value of the commodity.

BGP Litigation's team joined the proceedings at the cassation appeal stage.  The lawyers revised the defence strategy, focusing on application of Article 302 of the Russian Civil Code.  Having taken the account of the current case law of the Constitutional Court of the Russian Federation, our firm's dispute resolution practitioners substantiated the necessity of distinguishing between a disposal of property at an owner's will and a disposal against such will, even in case of a fraud.

In the cassation appeal, our dispute resolution professionals proved that in the case in question, the original owner had voluntarily performed the legally binding acts to transfer the commodity, for which reason the commodity had been withdrawn from his possession at his own will.

Following the review of the cassation appeal, the district commercial (arbitrazh) court reversed the appellate court's ruling and upheld the decision of the first instance court to reject the claim.

Our lawyers' position helped develop a precedent-setting approach to application of Article 302 of the Russian Civil Code.  The court upheld that a fraud conviction did not preclude the necessity of analysing the nature of the owner's intentions and the circumstances surrounding the property transfer.  Such an approach is essential for safeguarding bona fide purchasers and further development of the case law.

BGP Litigation's dispute resolution team engaged in the project comprised Partner Vladimir Efremov, Senior Associate Igor Vershinin, and Junior Associate Marfa Makarova.
04/08/2026 04/08/2026 Press-release
BGP Litigation Recognised as a Leading Law Firm in the Middle East: 2026 Research by Pravo.ru
03/26/2026 03/26/2026 Mass-media
BGP Litigation assisted the clients with recognition and enforcement of the Russian arbitral awards in Germany, Canada, and the UAE
02/13/2026 02/13/2026 Press-release
BGP Litigation’s Partner Vladimir Efremov Secures Spot Among Top 100 Most Influential Bankruptcy Professionals
07 08 09 10 11 12 01 02 03 04 05 06

Related practices and sectors